Antimicrobial Resistance of Haemophilus Influenzae Isolates from Pediatric Hospitals in Mainland China: Report from the ISPED Program, 2017-2019.
Mingming Zhou,Pan Fu,Chao Fang,Shiqiang Shang,Chunzhen Hua,Chunmei Jing,Hongmei Xu,Yunsheng Chen,Jikui Deng,Hong Zhang,Ting Zhang,Shifu Wang,Aiwei Lin,Weichun Huang,Qing Cao,Chuanqing Wang,Hui Yu,Sancheng Cao,Huiling Deng,Wei Gao,Jianhua Hao
DOI: https://doi.org/10.1016/j.ijmmb.2021.09.001
IF: 1.347
2021-01-01
Indian Journal of Medical Microbiology
Abstract:Purpose: This study set out to determine the antimicrobial resistance trends of Haemophilus influenzae isolates from pediatric hospitals in Mainland China, which would provide basis for clinical treatment. Methods: The Infectious Disease Surveillance of Pediatrics (ISPED) collaboration group conducted this study. H. influenzae strains isolated from nine pediatric hospitals in Mainland China were included. Disk diffusion method was used for antimicrobial susceptibility test. Cefinase disc was used for detection of beta-lactamase. Results: In total, 13810 H. influenzae isolates were included during 2017 -2019: 93.17% of which were from respiratory tract specimens, 4.63% from vaginal swabs, 1.10% from secretion, and 1.10% from others. Of all strains, 63.32% isolates produced beta-lactamase; 8.22% isolates were beta-lactamase-negative and ampicillin-resistant (BLNAR). The resistance to sulfamethoxazole-trimethoprim was 70.98%, followed by resistance to ampicillin (69.37%), cefuroxime (51.35%), ampicillin-sulbactam (38.82%), azithromycin (38.21%), amoxicillin-clavulanate (35.28%). More than 90% of H. influenzae isolates were susceptible to ceftriaxone, cefotaxime, meropenem, levofloxacin and chloramphenicol. The resistance rate of ampicillin and azithromycin in H. influenzae showed an increasing trend through the years. Statistically significant differences in antibiotic-resistance rates of all the antibiotics except chloramphenicol were found in different regions. The major Multi-Drug Resistance pattern was resistant to beta-lactams, macrolides, and sulfonamides. Conclusions: There is a rising trend of resistance rate of ampicillin and azithromycin in H. influenzae. Antimicrobial resistance of H. influenzae deserves our ongoing attention. Third-generation cephalosporin could be the preferred treatment option of infections caused by ampicillin-resistant H. influenzae.